ICYMI – Report highlights increasing prevalence for Alzheimer’s disease

The number of Americans affected by Alzheimer’s disease (AD) continues to rise according to a new report.1 Researchers found that approximately 6.08 million Americans had Alzheimer’s or mild...
Read More
Profiles in courage: Latinos in the fight against Alzheimer’s

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Medicare Monday: How finding an Alzheimer’s treatment could lower Medicare spending

Alzheimer’s disease is devastating and impacts more than 5.5 million Americans and their families. While America’s biopharmaceutical researchers have been working tirelessly to find a cure for the...
Read More
Continuing the search for new Alzheimer’s therapies

Designated in 1983 by then-President Ronald Reagan, November marks National Alzheimer’s Disease Awareness Month – a month for all Americans to come together to raise awareness and understanding of...
Read More
Dr. George Scangos: Not just science for science’s sake

America’s biopharmaceutical researchers are working tirelessly to develop new and innovative medicines for patients. For those diseases that have no treatment options, the opportunity to improve...
Read More
Using setbacks as stepping stones in Alzheimer’s research

For decades, biopharmaceutical researchers have worked tirelessly in the pursuit of new treatments and cures for the costly and devastating Alzheimer’s disease. Advancing treatments for Alzheimer’s...
Read More
Biopharmaceutical industry is essential to development of Alzheimer’s treatments

This week, presidential candidate Hillary Clinton called for a spending increase by the federal government to find a cure to the costly and devastating Alzheimer’s disease. Finding a better treatment...
Read More
Week in Review: The Latest from PhRMA

Neurological Disorders: America’s biopharmaceutical companies are committed to developing innovative new treatments for the nearly 50 million Americans affected by neurological disorders. This week,...
Read More
In Case You Missed It: Progress and Promise in Alzheimer’s Research

PhRMA recently convened a panel of health care experts for a live webcast discussion about the current state of research to treat and care for Alzheimer’s disease. Dr. Bill Chin of PhRMA moderated...
Read More
The War on Alzheimer’s: Progress and Challenges of Biopharmaceutical Research

Alzheimer’s disease steals memories, relationships and independence. It is a ruthless, devastating disease ravaging more than 5 million people in the United States alone, and is the sixth-leading...
Read More